| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue |
-
| 7,680 | 8,337 | | Cost of Revenue | 5,298 | 6,084 | 5,582 | | | Gross Profit | (5,298) | 1,596 | 2,755 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,964 | 15,492 | 13,715 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,262) | (13,896) | (10,960) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (181) | 846 | 556 | | Earnings Before Interest And Taxes | (9,443) | (13,050) | (9,404) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (9,443) | (13,050) | (9,404) | | Income Tax Expense |
-
| 1,084 | 13 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,443) | (14,134) | (10,417) | | | Non-recurring Events | | Discontinued Operations | 3,167 | 1,400 | 1,000 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (6,276) | (12,734) | (9,417) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,276) | ($12,734) | ($9,417) |
|
1.23% Nasdaq 
Income Statement
